Threats to laboratory workers come in many varieties, ranging from earthquakes to fires. But one threat that has acquired enhanced visibility in this age of bioterrorism is the threat of a laboratory-acquired infection.
Pneumococcal meningitis remains a deadly disease, with a case fatality rate among adults that is still above 20%, with also permanent neurological sequelae in a substantial minority of survivors.
In the health care setting, transmission of varicella zoster virus (VZV) from dermatomal herpes zoster lesions is generally felt to be insignificant, as long as the lesions are kept covered.
Exactly 1397 antiretroviral (ARV) naïve patients initiating ARVs, as part of a CPCRA-sponsored clinical trial (FIRST trial), were followed for a median of five years.
The utility of surveillance screening for MRSA on hospital admission remains controversial. Three recently published clinical trials attempt to assess the role of MRSA surveillance.
All patients admitted to the ICU at the Air Force Theater Hospital (Balad, Iraq) were followed prospectively for the development of VAP. There were 475 patients admitted to the ICU from May 2006 through August 2006.
In this Issue: Pioglitazone and heart disease; ARBs manufacturers spend millions to show the non-inferiority of their products compared to less expensive, generic ACE inhibitors; some athletes turn to growth hormone because it is difficult to detect; FDA Actions
More than 88% of home care telehealth providers report that the service has produced an increase in quality outcomes for their agencies by reducing hospitalizations and emergency department visits.